Zika virus to be investigated as novel glioblastoma treatment

Written by Martha Powell

In a new study, researchers will assess whether Zika virus can act against glioblastoma, one of the most difficult tumors to treat, with the hope that findings may lead to new therapeutics. Approximately 2300 individuals are diagnosed with glioblastoma in England every year and patients typically have low survival rates – less than 5% of patients will survive over 5 years. Current treatments face the challenge of crossing the blood–brain barrier and, as they are not tumor-specific, doses are often limited to avoid harming healthy tissue. Harry Bulstrode from the University of Cambridge (UK) will be leading the new study,...

To view this content, please register now for access

It's completely free